| Drug Type TCR-T Cell therapy | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism AFP inhibitors(Alpha-fetoprotein inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Advanced Hepatocellular Carcinoma | Phase 1 | China  | 10 Aug 2024 | |
| Hepatocellular Carcinoma | Phase 1 | China  | 10 Aug 2024 | 





